Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

March 26, 2013; 80 (13) In Focus

Spotlight on the March 26 Issue

Robert A. Gross
First published March 25, 2013, DOI: https://doi.org/10.1212/WNL.0b013e31828ac81e
Robert A. Gross
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Spotlight on the March 26 Issue
Robert A. Gross
Neurology Mar 2013, 80 (13) 1177; DOI: 10.1212/WNL.0b013e31828ac81e

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
499

Share

  • Article
  • Info & Disclosures
Loading

Pathways to neurodegeneration: Effects of HIV and aging on resting-state functional connectivity

This study used resting-state functional connectivity MRI (rs-fcMRI) to investigate within- and between-network connectivity among 5 functional brain networks in 58 HIV-infected participants and 53 HIV-uninfected controls. HIV-infected individuals showed decreases in rs-fcMRI intranetwork and internetwork correlations, leading to a baseline decrease in brain function similar to but independent of deterioration seen with aging.

See p. 1186; Editorial, p. 1178

Cognitive reserve associated with FDG-PET in preclinical Alzheimer diseaseEmbedded ImageEmbedded Image

The authors examined the effect of education on FDG-PET brain metabolism in 52 cognitively healthy subjects with preclinical Alzheimer disease (AD). Higher education was associated with lower FDG-PET activity in preclinical AD for a given level of cognitive performance, suggesting that cognitive reserve has a compensatory function to sustain cognitive ability in presence of early AD pathology and hypometabolism.

Embedded Image

See p. 1194, p. 1202; Editorial, p. 1180

Neural reserve, neuronal density in the locus ceruleus, and cognitive decline

In 165 older persons, higher density of noradrenergic neurons in the locus ceruleus was associated with slower cognitive decline, even when controlling for neurodegenerative markers, and modified the correlation of Lewy bodies with cognitive decline. Density of noradrenergic neurons in the locus ceruleus may be a structural component of neural reserve.

See p. 1202, p. 1194; Editorial, p. 1180

Infectious burden and cognitive function: The Northern Manhattan Study

Serologies and cognitive assessments were available in 1,625 participants of the Northern Manhattan Study cohort. In unadjusted analyses, higher infectious burden index was associated with worse cognition as assessed by the Mini-Mental State Examination and the modified Telephone Interview for Cognitive Status. Previous infections may contribute to cognitive impairment.

See p. 1209

From editorialists Strandberg & Aiello: “According to the current state of knowledge, an ideal trial to prove the microbe–dementia connection would involve not only antiviral but also antibacterial (e.g., spirochete or chlamydia) and anti-inflammatory therapy.”

See p. 1182

Hypertension at time of diagnosis and long-term outcome after childhood ischemic stroke

At the time of first stroke, 53 of 84 pediatric patients with available blood pressure readings had at least 1 episode of hypertension, and 19 had hypertension on 3 consecutive days. Hypertension was thus prevalent in children with ischemic stroke and was associated with an increased risk of death.

See p. 1225

Time to pediatric epilepsy surgery is related to disease severity and nonclinical factors

Data were abstracted from records of 430 children who had epilepsy neurosurgery from 1986 to 2010. Shorter intervals to surgical treatment were associated with greater epilepsy severity and insurance type. Shorter times to treatment were also associated with having a brain MRI before referral or Hispanic ethnicity; such findings were unexpected and warrant further investigation to uncover the reasons for more rapid referral.

See p. 1231

Hippocampal volume and cell density changes in a mouse model of human genetic epilepsy

Pre-epilepsy structural differences may be fundamental to understanding susceptibility for seizures. In a validated seizure-naive genetic mouse model of human epilepsy that has febrile seizure susceptibility, there were increases in MRI hippocampal dentate granule cell volume and density, suggesting a morphologic biomarker for seizure susceptibility.

See p. 1240

VIEWS & REVIEWS

Pediatric neuroenhancement: Ethical, legal, social, and neurodevelopmental implicationsEmbedded Image

This ethics position paper on pediatric neuroenhancement is a follow-up to the 2009 Ethics, Law and Humanities Committee guidance statement on adult neuroenhancement. In healthy and developmentally nonautonomous children and adolescents, neuroenhancement is not justifiable.

See p. 1251

Footnotes

  • NB: “Neuro kids,” see p. e132. To check out other Reflections: Neurology and the Humanities, point your browser to www.neurology.org.

  • © 2013 American Academy of Neurology

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Pathways to neurodegeneration: Effects of HIV and aging on resting-state functional connectivity
    • Cognitive reserve associated with FDG-PET in preclinical Alzheimer disease
    • Neural reserve, neuronal density in the locus ceruleus, and cognitive decline
    • Infectious burden and cognitive function: The Northern Manhattan Study
    • Hypertension at time of diagnosis and long-term outcome after childhood ischemic stroke
    • Time to pediatric epilepsy surgery is related to disease severity and nonclinical factors
    • Hippocampal volume and cell density changes in a mouse model of human genetic epilepsy
    • VIEWS & REVIEWS
    • Footnotes
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 96 (15)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2021 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise